Synovial fluid proteomics in the pursuit of arthritis mediators: An evolving field of novel biomarker discovery

References

• Song J, Chang HJ, Tirodkar M, et al. Racial/ethnic differences in activities of daily living disability in older adults with arthritis: a longitudinal study. Arthritis Rheum. 2007;57:1058–1066.
   PubMedGoogle Scholar
• Hootman JM, Helmick CG, Brady TJ. A public health approach to addressing arthritis in older adults: the most common cause of disability. Am J Public Health. 2012;102:426–433.
   PubMed Web of Science ®Google Scholar
• Lagacé C, O’Donnell S, McRae L, et al. Life with arthritis in Canada: a personal and public health challenge. Ottawa: Public Health Agency of Canada; 2010:128.
   Google Scholar
• Centers for Disease Control and Prevention. Arthritis as a potential barrier to physical activity among adults with diabetes – United States, 2005 and 2007. MMWR Morb Mortal Wkly Rep. 2008;57:486–489.
   PubMedGoogle Scholar
• Centers for Disease Control and Prevention. Arthritis as a potential barrier to physical activity among adults with heart disease – United States, 2005 and 2007. MMWR Morb Mortal Wkly Rep. 2009;58:165–169.
   PubMedGoogle Scholar
• Sophia Fox AJ, Bedi A, Rodeo SA. The basic science of articular cartilage: structure, composition, and function. Sports Health. 2009;1:461–468.
   PubMedGoogle Scholar
• Gibson DS, Rooney ME. The human synovial fluid proteome: a key factor in the pathology of joint disease. Prot Clin Appl. 2007;1:889–899.
   PubMed Web of Science ®Google Scholar
• Hui AY, McCarty WJ, Masuda K, et al. A systems biology approach to synovial joint lubrication in health, injury, and disease. Wires Syst Biol Med. 2012;4:15–37.
   PubMed Web of Science ®Google Scholar
• Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the best study): a randomized, controlled trial. Arthritis Rheum. 2005;52:3381–3390.
   PubMed Web of Science ®Google Scholar
• Ahmed U, Anwar A, Savage RS, et al. Biomarkers of early stage osteoarthritis, rheumatoid arthritis and musculoskeletal health. Sci Rep. 2015;5:9259.
   PubMed Web of Science ®Google Scholar
• Nielsen SF, Bojesen SE, Schnohr P, et al. Elevated rheumatoid factor and long term risk of rheumatoid arthritis: a prospective cohort study. BMJ. 2012;345.
   Google Scholar
• Liao H, Wu J, Kuhn E, et al. Use of mass spectrometry to identify protein biomarkers of disease severity in the synovial fluid and serum of patients with rheumatoid arthritis. Arthritis Rheum. 2004;50:3792–3803.
   PubMed Web of Science ®Google Scholar
• Rousseau JC, Delmas PD. Biological markers in osteoarthritis. Nat Clin Pract Rheumatol. 2007;3:346–356.
   PubMedGoogle Scholar
• Thomas GP, Brown MA. Genetics and genomics of ankylosing spondylitis. Immunol Rev. 2010;233:162–180.
   PubMed Web of Science ®Google Scholar
• Castro C, Gourley M. Diagnostic testing and interpretation of tests for autoimmunity. J Allergy Clin Immunol. 2010;125:S238–SS47.
   PubMed Web of Science ®Google Scholar
• Qaseem A, McLean RM, Starkey M, et al. For the Clinical Guidelines Committee of the American College of P. Diagnosis of acute gout: a clinical practice guideline from the American College of Physicians. Ann Intern Med. 2017;66:52–57.
   Web of Science ®Google Scholar
• Ruiz-Romero C, Blanco FJ. Proteomics role in the search for improved diagnosis, prognosis and treatment of osteoarthritis. Osteoarthritis Cartilage. 2010;18:500–509.
   PubMed Web of Science ®Google Scholar
• Wilkinson M, Jones BS. Serum and synovial fluid proteins in arthritis. Ann Rheum Dis. 1962;21:51–58.
   PubMed Web of Science ®Google Scholar
• Parker CE, Borchers CH. Mass spectrometry based biomarker discovery, verification, and validation – quality assurance and control of protein biomarker assays. Mol Oncol. 2014;8:840–858.
   Google Scholar
• Drabovich AP, Martinez-Morillo E, Diamandis EP. Toward an integrated pipeline for protein biomarker development. Biochim Biophys Acta. 2015;1854:677–686.
   PubMed Web of Science ®Google Scholar
• Cretu D, Prassas I, Saraon P, et al. Identification of psoriatic arthritis mediators in synovial fluid by quantitative mass spectrometry. Clin Proteomics. 2014;11:1–12.
   PubMed Web of Science ®Google Scholar
• Balakrishnan L, Bhattacharjee M, Ahmad S, et al. Differential proteomic analysis of synovial fluid from rheumatoid arthritis and osteoarthritis patients. Clin Proteomics. 2014;11:1.
   PubMed Web of Science ®Google Scholar
• Matsuo K, Xiang Y, Nakamura H, et al. Identification of novel citrullinated autoantigens of synovium in rheumatoid arthritis using a proteomic approach. Arthritis Res Ther. 2006;8:R175–R17R.
   PubMed Web of Science ®Google Scholar
• Marvin LF, Roberts MA, Fay LB. Matrix-assisted laser desorption/ionization time-of-flight mass spectrometry in clinical chemistry. Clin Chim Acta. 2003;337:11–21.
   PubMed Web of Science ®Google Scholar
• Mateos J, Lourido L, Fernandez-Puente P, et al. Differential protein profiling of synovial fluid from rheumatoid arthritis and osteoarthritis patients using lc-maldi tof/tof. J Proteomics. 2012;75:2869–2878.
   PubMed Web of Science ®Google Scholar
• Gharbi M, Deberg M, Henrotin Y. Application for proteomic techniques in studying osteoarthritis: a review. Front Physiol. 2011;2:90.
   PubMed Web of Science ®Google Scholar
• Yates JR, Ruse CI, Nakorchevsky A. Proteomics by mass spectrometry: approaches, advances, and applications. Annu Rev Biomed Eng. 2009;11:49–79.
   PubMed Web of Science ®Google Scholar
• Chen G, Pramanik BN. Application of lc/ms to proteomics studies: current status and future prospects. Drug Discov Today. 2009;14:465–471.
   PubMed Web of Science ®Google Scholar
• Mann M. Functional and quantitative proteomics using silac. Nat Rev Mol Cell Biol. 2006;7:952–958.
   PubMed Web of Science ®Google Scholar
• Shiio Y, Aebersold R. Quantitative proteome analysis using isotope-coded affinity tags and mass spectrometry. Nat Protoc. 2006;1:139–145.
   PubMed Web of Science ®Google Scholar
• Wiese S, Reidegeld KA, Meyer HE, et al. Protein labeling by itraq: a new tool for quantitative mass spectrometry in proteome research. Proteomics. 2007;7:340–350.
   PubMed Web of Science ®Google Scholar
• Megger DA, Bracht T, Meyer HE, et al. Label-free quantification in clinical proteomics. Biochim Biophys Acta. 2013;1834:1581–1590.
   PubMed Web of Science ®Google Scholar
• Arike L, Peil L. Spectral counting label-free proteomics. Methods Mol Biol. 2014;1156:213–222.
   PubMedGoogle Scholar
• Chelius D, Bondarenko PV. Quantitative profiling of proteins in complex mixtures using liquid chromatography and mass spectrometry. J Proteome Res. 2002;1:317–323.
   PubMed Web of Science ®Google Scholar
• Higgs RE, Knierman MD, Gelfanova V, et al. Comprehensive label-free method for the relative quantification of proteins from biological samples. J Proteome Res. 2005;4:1442–1450.
   PubMed Web of Science ®Google Scholar
• Wang Q, Rozelle AL, Lepus CM, et al. Identification of a central role for complement in osteoarthritis. Nat Med. 2011;17:1674–1679.
   PubMed Web of Science ®Google Scholar
• Livshits G, Zhai G, Hart DJ, et al. Interleukin-6 is a significant predictor of radiographic knee osteoarthritis: the Chingford study. Arthritis Rheum. 2009;60:2037–2045.
   PubMed Web of Science ®Google Scholar
• Verma P, Dalal K. Serum cartilage oligomeric matrix protein (comp) in knee osteoarthritis: a novel diagnostic and prognostic biomarker. J Orthop Res. 2013;31:999–1006.
   PubMed Web of Science ®Google Scholar
• Maksymowych WP, Marotta A. 14-3-3η: a novel biomarker platform for rheumatoid arthritis. Clin Exp Rheumatol. 2014;32:S-35
   Web of Science ®Google Scholar
• Nordal HH, Brokstad KA, Solheim M, et al. Calprotectin (s100a8/a9) has the strongest association with ultrasound-detected synovitis and predicts response to biologic treatment: results from a longitudinal study of patients with established rheumatoid arthritis. Arthritis Res Ther. 2017;19:3.
   PubMed Web of Science ®Google Scholar
• Hammer HB, Odegard S, Syversen SW, et al. Calprotectin (a major s100 leucocyte protein) predicts 10-year radiographic progression in patients with rheumatoid arthritis. Ann Rheum Dis. 2010;69:150–154.
   Web of Science ®Google Scholar
• Hammer HB, Ødeg̊ard S, Fagerhol MK, et al. Calprotectin (a major leucocyte protein) is strongly and independently correlated with joint inflammation and damage in rheumatoid arthritis. Ann Rheum Dis. 2007;66:1093–1097.
   PubMed Web of Science ®Google Scholar
• Balakrishnan L, Nirujogi RS, Ahmad S, et al. Proteomic analysis of human osteoarthritis synovial fluid. Clin Proteomics. 2014;11:6.
   PubMed Web of Science ®Google Scholar
• Gobezie R, Kho A, Krastins B, et al. High abundance synovial fluid proteome: distinct profiles in health and osteoarthritis. Arthritis Res Ther. 2007;9:R36.
   PubMed Web of Science ®Google Scholar
• Hillmen P, Young NS, Schubert J, et al. The complement inhibitor eculizumab in paroxysmal nocturnal hemoglobinuria. N Engl J Med. 2006;355:1233–1243.
   PubMed Web of Science ®Google Scholar
• Brodsky RA, Young NS, Antonioli E, et al. Multicenter phase 3 study of the complement inhibitor eculizumab for the treatment of patients with paroxysmal nocturnal hemoglobinuria. Blood. 2008;111:1840–1847.
   PubMed Web of Science ®Google Scholar
• Wanner JP, Subbaiah R, Skomorovska-Prokvolit Y, et al. Proteomic profiling and functional characterization of early and late shoulder osteoarthritis. Arthritis Res Ther. 2013;15:R180.
   PubMed Web of Science ®Google Scholar
• Kokebie R, Aggarwal R, Lidder S, et al. The role of synovial fluid markers of catabolism and anabolism in osteoarthritis, rheumatoid arthritis and asymptomatic organ donors. Arthritis Res Ther. 2011;13:R50.
   PubMed Web of Science ®Google Scholar
• Tsuchida AI, Beekhuizen M, Rutgers M, et al. Interleukin-6 is elevated in synovial fluid of patients with focal cartilage defects and stimulates cartilage matrix production in an in vitro regeneration model. Arthritis Res Ther. 2012;14:R262.
   PubMed Web of Science ®Google Scholar
• Kaneko S, Satoh T, Chiba J, et al. Interleukin-6 and interleukin-8 levels in serum and synovial fluid of patients with osteoarthritis. Cytokines Cell Mol Ther. 2000;6:71–79.
   PubMed Web of Science ®Google Scholar
• El-Arman MM, El-Fayoumi G, El-Shal E, et al. Aggrecan and cartilage oligomeric matrix protein in serum and synovial fluid of patients with knee osteoarthritis. HSS J. 2010;6:171–176.
   PubMedGoogle Scholar
• Biswas S, Sharma S, Saroha A, et al. Identification of novel autoantigen in the synovial fluid of rheumatoid arthritis patients using an immunoproteomics approach. PLoS One. 2013;8:e56246.
   PubMed Web of Science ®Google Scholar
• Young BJ, Mallya RK, Leslie RD, et al. Anti-keratin antibodies in rheumatoid arthritis. Br Med J. 1979;2:97–99.
   PubMed Web of Science ®Google Scholar
• Nielen MM, van Schaardenburg D, Reesink HW, et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum. 2004;50:380–386.
   PubMed Web of Science ®Google Scholar
• Young KA, Deane KD, Derber LA, et al. Relatives without rheumatoid arthritis show reactivity to anti-citrullinated protein/peptide antibodies that are associated with arthritis-related traits: studies of the etiology of rheumatoid arthritis. Arthritis Rheum. 2013;65:1995–2004.
   PubMedGoogle Scholar
• Kilani RT, Maksymowych WP, Aitken A, et al. Detection of high levels of 2 specific isoforms of 14-3-3 proteins in synovial fluid from patients with joint inflammation. J Rheumatol. 2007;34:1650–1657.
   PubMed Web of Science ®Google Scholar
• Hughes N, Boss S, Longe R, et al. Ab0079 independent validation of 14-3-3eta assay reproducibility, consistent with omeract soluble biomarker criteria. Ann Rheum Dis. 2015;74:917.
   Web of Science ®Google Scholar
• Segurado OG, Sasso EH. Vectra da for the objective measurement of disease activity in patients with rheumatoid arthritis. Clin Exp Rheumatol. 2014;32:S29–S34.
   Web of Science ®Google Scholar
• Bhattacharjee M, Sharma R, Goel R, et al. A multilectin affinity approach for comparative glycoprotein profiling of rheumatoid arthritis and spondyloarthropathy. Clin Proteomics. 2013;10:11.
   PubMed Web of Science ®Google Scholar
• Baillet A, Trocmé C, Berthier S, et al. Synovial fluid proteomic fingerprint: S100a8, s100a9 and s100a12 proteins discriminate rheumatoid arthritis from other inflammatory joint diseases. Rheumatology. 2010;49:671–682.
   PubMed Web of Science ®Google Scholar
• Sinz A, Bantscheff M, Mikkat S, et al. Mass spectrometric proteome analyses of synovial fluids and plasmas from patients suffering from rheumatoid arthritis and comparison to reactive arthritis or osteoarthritis. Electrophoresis. 2002;23:3445–3456.
   PubMed Web of Science ®Google Scholar
• Drynda S, Ringel B, Kekow M, et al. Proteome analysis reveals disease-associated marker proteins to differentiate ra patients from other inflammatory joint diseases with the potential to monitor anti-tnfalpha therapy. Pathol Res Pract. 2004;200:165–171.
   PubMed Web of Science ®Google Scholar
• Leach ST, Yang Z, Messina I, et al. Serum and mucosal s100 proteins, calprotectin (s100a8/s100a9) and s100a12, are elevated at diagnosis in children with inflammatory bowel disease. Scand J Gastroenterol. 2007;42:1321–1331.
   PubMed Web of Science ®Google Scholar
• Feldmann M, Brennan FM, Maini RN. Rheumatoid arthritis. Cell. 1996;85:307–310.
   PubMed Web of Science ®Google Scholar
• Yoshihara Y, Nakamura H, Obata K, et al. Matrix metalloproteinases and tissue inhibitors of metalloproteinases in synovial fluids from patients with rheumatoid arthritis or osteoarthritis. Ann Rheum Dis. 2000;59:455–461.
   PubMed Web of Science ®Google Scholar
• Tchetverikov I, Ronday HK, Van El B, et al. Mmp profile in paired serum and synovial fluid samples of patients with rheumatoid arthritis. Ann Rheum Dis. 2004;63:881–883.
   PubMed Web of Science ®Google Scholar
• Hemmings FJ, Farhan M, Rowland J, et al. Tolerability and pharmacokinetics of the collagenase-selective inhibitor trocade in patients with rheumatoid arthritis. Rheumatology (Oxford). 2001;40:537–543.
   PubMed Web of Science ®Google Scholar
• Lee DY, Huang CM, Nakatsuji T, et al. Histone h4 is a major component of the antimicrobial action of human sebocytes. J Invest Dermatol. 2009;129:2489–2496.
   PubMedGoogle Scholar
• Dohrmann S, LaRock CN, Anderson EL, et al. Group a streptococcal m1 protein provides resistance against the antimicrobial activity of histones. Sci Rep. 2017;7:43039.
   PubMed Web of Science ®Google Scholar
• Vasey FB, Deitz C, Fenske NA, et al. Possible involvement of group a streptococci in the pathogenesis of psoriatic arthritis. J Rheumatol. 1982;9:719–722.
   PubMed Web of Science ®Google Scholar
• Scrivo R, Conigliaro P, Riccieri V, et al. Distribution of interleukin-10 family cytokines in serum and synovial fluid of patients with inflammatory arthritis reveals different contribution to systemic and joint inflammation. Clin Exp Immunol. 2015;179:300–308.
   PubMed Web of Science ®Google Scholar
• Kundu-Raychaudhuri S, Abria C, Raychaudhuri SP. Il-9, a local growth factor for synovial t cells in inflammatory arthritis. Cytokine. 2016;79:45–51.
   PubMed Web of Science ®Google Scholar
• Guggino G, Ciccia F, Di Liberto D, et al. Interleukin (il)-9/il-9r axis drives γδ T cells activation in psoriatic arthritis patients. Clin Exp Immunol. 2016;186:277–283.
   PubMed Web of Science ®Google Scholar
• Gibson DS, Finnegan S, Jordan G, et al. Stratification and monitoring of juvenile idiopathic arthritis patients by synovial proteome analysis. J Proteome Res. 2009;8:5601–5609.
   PubMed Web of Science ®Google Scholar
• Gibson DS, Blelock S, Brockbank S, et al. Proteomic analysis of recurrent joint inflammation in juvenile idiopathic arthritis. J Proteome Res. 2006;5:1988–1995.
   PubMed Web of Science ®Google Scholar
• Rosenkranz ME, Wilson DC, Marinov AD, et al. Synovial fluid proteins differentiate between the subtypes of juvenile idiopathic arthritis. Arthritis Rheum. 2010;62:1813–1823.
   PubMed Web of Science ®Google Scholar
• Gibson DS, Newell K, Evans AN, et al. Vitamin d binding protein isoforms as candidate predictors of disease extension in childhood arthritis. J Proteomics. 2012;75:5479–5492.
   PubMed Web of Science ®Google Scholar
• Blaschke S, Rinke K, Maring M, et al. Haptoglobin-α1, -α2, vitamin d-binding protein and apolipoprotein c-iii as predictors of etanercept drug response in rheumatoid arthritis. Arthritis Res Ther. 2015;17:45.
   PubMed Web of Science ®Google Scholar
• Diamandis EP. Cancer biomarkers: can we turn recent failures into success? J Natl Cancer Inst. 2010;102:1462–1467.
   PubMedGoogle Scholar